Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Ajanta Pharma Ltd.
NSE: AJANTPHARM
|
BSE: 532331
|
ISIN: INE031B01049
|
Industry: Pharmaceuticals
|
Expensive Performer
2595.5000
-6.75
(
-0.26
%)
NSE
Mar 19, 2025
10:00 AM
25.52% Fall from 52W High
Volume:
12,791
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Ajanta Pharma Ltd.
30 Jul 2020
2595.50
-0.26%
Ajanta Pharma (BUY): Solid beat on margins set to normalise in coming quarters
Buy:
Ajanta Pharma Ltd.
by
BOB Capital Markets Ltd.
Target: 1730
Target
BOB Capital Markets Ltd.
Ajanta Pharma (AJP) posted Q1 revenue/EBITDA growth of 9%/33% YoY to Rs 6.7bn/Rs 2.2bn.
Ajanta Pharma Ltd. is trading below all available SMAs
More from Ajanta Pharma Ltd.
Recommended
Market opens higher, Bajaj Auto reappoints Rajivnayan Bajaj as MD & CEO from April 1
Trendlyne Marketwatch |
19 Mar 2025, 09:46AM
Five stocks to buy from analysts this week - March 18, 2025
The Baseline |
18 Mar 2025, 05:17PM
Ajanta Pharma disputes ET article on FDA import alert
|
24 Jan 2017